San Diego-based mostly Viking Therapeutics marked alone as a significant competitor inside the weight loss drug marketplace in February soon after revealing promising details from the mid-stage trial of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when supplied for a weekly injection As well as in Mar